Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
作者： Jennifer G. Robinson , Anne C. Goldberg
DOI: 10.1016/J.JACL.2011.03.451
关键词:
摘要: Patients with familial hypercholesterolemias (FH) are at greatly increased lifetime risk of cardiovascular disease (CVD). If left untreated, most individuals FH will experience premature coronary heart (CHD) and/or stroke. The mean age onset a event in men is the early 40s and women 50s. Although fewer than 5% acute myocardial infarctions (AMI) occur #40 years age, associated 24-fold increase infarction by 40. In western countries, prevalence CVD middle-aged ranges from 22% to 39%. Therefore, all FH, regardless require lifestyle drug
lipidjournal.com
elsevier.com参考文章(81)
Clofibrate and Niacin in Coronary Heart Disease JAMA. ,vol. 231, pp. 360- 381 ,(1975) , 10.1001/JAMA.1975.03240160024021
J. N. Et Al. Morris, Controlled trial of soyabean oil in myocardial infarction. The Lancet. ,vol. 2, pp. 693- 700 ,(1968)
S. E. Kjeldsen, M. L. Larsen, G. Mancia, A. J. Manolis, K. Orth-Gomer, T. Pedersen, M. Rayner, L. Ryden, M. Sammut, N. Schneiderman, A. F. Stalenhoef, L. Tokgozoglu, O. Wiklund, A. Zampelas, , , , , I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, B. Gjelsvik, C. Herrmann-Lingen, A. Hoes, S. Humphries, M. Knapton, J. Perk, S. G. Priori, K. Pyorala, Z. Reiner, L. Ruilope, S. Sans-Menendez, W. Scholte op Reimer, P. Weissberg, D. Wood, J. Yarnell, J. L. Zamorano, E. Walma, T. Fitzgerald, M. T. Cooney, A. Dudina, A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, C. Funck-Brentano, G. Filippatos, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, I. Hellemans, A. Altiner, E. Bonora, P. N. Durrington, R. Fagard, S. Giampaoli, H. Hemingway, J. Hakansson, European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). European Heart Journal. ,vol. 28, pp. 2375- 2414 ,(2007) , 10.1093/EURHEARTJ/EHM316
, J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, M. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cifkova, C. Deaton, S. Ebrahim, M. Fisher, G. Germano, R. Hobbs, A. Hoes, S. Karadeniz, A. Mezzani, E. Prescott, L. Ryden, M. Scherer, M. Syvanne, W. J. M. Scholte Op Reimer, C. Vrints, D. Wood, J. L. Zamorano, F. Zannad, M. T. Cooney, J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, C. Funck-Brentano, P. A. Sirnes, V. Aboyans, E. A. Ezquerra, C. Baigent, C. Brotons, G. Burell, A. Ceriello, J. De Sutter, J. Deckers, S. Del Prato, H.-C. Diener, D. Fitzsimons, Z. Fras, R. Hambrecht, P. Jankowski, U. Keil, M. Kirby, M. L. Larsen, G. Mancia, A. J. Manolis, J. McMurray, A. Pajak, A. Parkhomenko, L. Rallidis, F. Rigo, E. Rocha, L. M. Ruilope, E. van der Velde, D. Vanuzzo, M. Viigimaa, M. Volpe, O. Wiklund, C. Wolpert, , , , European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) European Heart Journal. ,vol. 33, pp. 1635- 1701 ,(2012) , 10.1093/EURHEARTJ/EHS092
S Tudy G Roup, I An F Ord, S Tuart M. C Obbe, C Hristopher G. I Sles, J Ames S Hepherd, C Hristopher J. P Ackard, P Eter W. M Acfarlane, J Ames H. M C K Illop, A. R Oss L Orimer, PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA ,(1995)
Pierluigi Costanzo, Pasquale Perrone-Filardi, Enrico Vassallo, Stefania Paolillo, Paolo Cesarano, Gregorio Brevetti, Massimo Chiariello, Does Carotid Intima-Media Thickness Regression Predict Reduction of Cardiovascular Events?: A Meta-Analysis of 41 Randomized Trials Journal of the American College of Cardiology. ,vol. 56, pp. 2006- 2020 ,(2010) , 10.1016/J.JACC.2010.05.059
John J.P. Kastelein, Philip T. Sager, Eric de Groot, Enrico Veltri, Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia: Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial American Heart Journal. ,vol. 149, pp. 234- 239 ,(2005) , 10.1016/J.AHJ.2004.06.024
Peter A. McCullough, Annual Progression of Coronary Calcification in Trials of Preventive Therapies Archives of Internal Medicine. ,vol. 169, pp. 2064- 2070 ,(2009) , 10.1001/ARCHINTERNMED.2009.382
John JP Kastelein, Wim A Van Der Steeg, Ingar Holme, Michael Gaffney, Nilo B Cater, Philip Barter, Prakash Deedwania, Anders G Olsson, S Matthijs Boekholdt, David A Demicco, Michael Szarek, John C LaRosa, Terje R Pedersen, Scott M Grundy, None, Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment Circulation. ,vol. 117, pp. 3002- 3009 ,(2008) , 10.1161/CIRCULATIONAHA.107.713438
F. Wiesbauer, H. Blessberger, D. Azar, G. Goliasch, O. Wagner, L. Gerhold, K. Huber, K. Widhalm, F. Abdolvahab, G. Sodeck, G. Maurer, M. Schillinger, Familial-combined hyperlipidaemia in very young myocardial infarction survivors (≤40 years of age) European Heart Journal. ,vol. 30, pp. 1073- 1079 ,(2009) , 10.1093/EURHEARTJ/EHP051